article thumbnail

How biotech and pharma companies pay their CEOs, and their workers

Bio Pharma Dive

The median CEO of 231 drug companies analyzed by BioPharma Dive earned 50% more last year than in 2017, a leap that far outpaced the more modest pay gains among employees.

article thumbnail

Pharma companies must adapt to keep pace with AI developments, say experts

Pharmaceutical Technology

At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma companies boost drug prices to start year, but hikes lag inflation

Bio Pharma Dive

Analysts noted hundreds of wholesale price increases, including dozens by Pfizer. Many checked in around 5%, roughly in line with hikes taken in recent years.

article thumbnail

Supply chain & logistics innovation among pharma companies has dropped off in the last year

Pharmaceutical Technology

The post Supply chain & logistics innovation among pharma companies has dropped off in the last year appeared first on Pharmaceutical Technology. Hoffmann-La Roche Ltd (3 applications), and the United States based Thermo Fisher Scientific Inc (1 applications).

article thumbnail

For pharma companies, the possibilities of green chemistry are huge

Pharmaceutical Technology

Green chemistry has the potential to revolutionise the pharmaceutical industry.

article thumbnail

Era of ADCs: Pharma companies innovate to stand out in a buzzing market

Pharmaceutical Technology

As antibody drug conjugate (ADC)-centred deals dominate the oncology space, biotechs are using newer targets and linkers to differentiate themselves.

article thumbnail

IISc researchers find picolinic acid’s broad-spectrum antiviral abilities, scouts for partners in pharma companies

AuroBlog - Aurous Healthcare Clinical Trials blog

The Institute is now looking for partners in pharma companies to pursue further clinical development of the findings. Researchers at the Indian Institute of Science (IISc) have found that picolinic acid, a natural compound produced by mammalian cells, can block several disease-causing viruses such as SARS-CoV-2 and influenza A viruses.